News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Increasing the dose intensity of chemotherapy by either shortening the intervals between the cycles or…
Adding the CDK4/6 inhibitor ribociclib to standard endocrine therapy with temporary ovarian suppression significantly improved…
A combination of pembrolizumab and trastuzumab, tested in patients with trastuzumab-resistant advanced HER2-positive breast cancer,…
A study that looked at mainstreaming genetic counselling for ovarian cancer to support screening programmes…
The Clinical Oncology Society of Australia Annual Scientific Meeting showcased new insights in the field…
With a theme this year of “Immunotherapy: Molecules and Mountains” the 44th Annual Scientific Meeting…
A small but enthusiastic group of people gathered on the eve of the COSA ASM…
The relentless efforts devoted to improving prevention, early detection, and treatment have resulted in more…
Women with higher body mass index (BMI) face an increased risk of not detecting their…
Metastatic or castrate-resistant prostate cancer can spread to the bone in certain patients. While several…